OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 01, 2015
Currently, pharma has only scratched the surface of the potential value of repurposing drugs, says consultant Hermann Mucke. Contract service partners are playing a more prominent role, but could play an even larger one in these efforts.
Sponsors and contract partners alike should not assume that upcoming US federal deadlines will be as elastic as California’s were.
July 31, 2015
Investment in Powdersize adds particle-size control solutions to Xcelience’s capabilities.
Lupin acquires businesses in Germany, the US, Russia, Brazil, and South Africa.
Avista grows its contract services business, and Scynexis focuses on antifungal development.
July 16, 2015
AMRI expands its API portfolio and European presence through acquisition of Gadea’s Crystal Pharma Group.
Evans Analytical Group expands into the pharmaceutical/biopharmaceutical industry with acquisition of ABC Laboratories.
July 07, 2015
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable the manufacture of multiple recombinant antibodies in a single batch culture.
Keith Moore will support Metrics Contract Services as vice president of analytical services.
July 02, 2015
While all market signs are pointing up, memories of past setbacks may discourage from expanding capacity.